Juncai Ye, Min Hou, Daiyuan Ma, Yan Gui. "Cadonilimab combined with anlotinib in patients with advanced NSCLC refractory to prior systemic therapy and anti–PD-(L)1 antibodies: A phase II study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e20507